Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Eve A, Kerr"'
Autor:
Jordan B Sparks, Mandi L Klamerus, Tanner J Caverly, Sarah E Skurla, Timothy P Hofer, Eve A Kerr, Steven J Bernstein, Laura J Damschroder
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 8, p e33898 (2022)
BackgroundThe RAND/UCLA Appropriateness Method (RAM), a variant of the Delphi Method, was developed to synthesize existing evidence and elicit the clinical judgement of medical experts on the appropriate treatment of specific clinical presentations.
Externí odkaz:
https://doaj.org/article/9e6afc4f3f9b47a18793e630ce314a9c
Autor:
Erika D. Sears, Richard Evans, Jennifer Burns, Kevin C. Chung, Rodney A. Hayward, Eve A. Kerr
Publikováno v:
Medical care. 61(1)
Few performance measures assess presurgical value (quality and utilization).Using carpal tunnel syndrome (CTS) as a case study: (1) develop a model to evaluate presurgical quality and utilization and (2) identify opportunities for value improvement.A
Publikováno v:
International Journal of Cardiology. Hypertension, Vol 9, Iss , Pp 100098- (2021)
Background: New hypertension performance measures encourage more intensive treatment in older adults. Treatment intensification includes starting new medications and increasing the dose of old ones. Medication dose is particularly important to older
Externí odkaz:
https://doaj.org/article/dc86901d79d2462d9e235d3281eda48a
Publikováno v:
Journal of Comorbidity, Vol 11 (2021)
Background: Inappropriate prescribing is frequent in older adults and associated with adverse outcomes. Prescribing indications aim to optimize prescribing, but little is known about the focus and features of prescribing indications for the most comm
Externí odkaz:
https://doaj.org/article/f4fd22fa12154ce9a3b9f31391936d8a
Autor:
Garth W. Strohbehn, Robert Holleman, Jennifer Burns, Mandi L. Klamerus, Michael J. Kelley, Eve A. Kerr, Nithya Ramnath, Timothy P. Hofer
Publikováno v:
JAMA oncology. 8(11)
ImportanceExtended-interval dosing of pembrolizumab (400 mg every 6 weeks) was approved by US Food and Drug Administration (FDA) in April 2020 as an alternative to standard-interval dosing (200 mg every 3 weeks). Extended-interval dosing may enhance
Autor:
Ann-Marie Rosland, John D. Piette, Ranak Trivedi, Eve A. Kerr, Shelley Stoll, Adam Tremblay, Michele Heisler
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-16 (2018)
Abstract Background Most adults with diabetes who are at high risk for complications have family or friends who are involved in their medical and self-care (“family supporters”). These family supporters are an important resource who could be leve
Externí odkaz:
https://doaj.org/article/9782663ace47420aa50bda05c006e833
Publikováno v:
Journal of General Internal Medicine.
Publikováno v:
Preventive Medicine Reports, Vol 6, Iss C, Pp 322-328 (2017)
To increase the likelihood of successful implementation of interventions and promote dissemination across real-world settings, it is essential to evaluate outcomes related to dimensions other than Effectiveness alone. Glasgow and colleagues' RE-AIM f
Externí odkaz:
https://doaj.org/article/235379b9436845dd80cf543b2f0540f9
Autor:
Katherine Wilkinson, Robert G. Holleman, Eve A. Kerr, James Henderson, R. Sacha Bhatia, Mandi L. Klamerus, Timothy P. Hofer
Publikováno v:
The American Journal of Managed Care. 27:438-444
OBJECTIVES To quantify the extent of patient-level agreement among 3 published measures of low-value imaging for acute low back pain (LBP). STUDY DESIGN In this retrospective cohort study using commercial insurance claims from MarketScan, we assessed
Autor:
Carole E. Aubert, James B. Henderson, Eve A. Kerr, Rob Holleman, Mandi L. Klamerus, Timothy P. Hofer
Publikováno v:
Journal of General Internal Medicine
Background The COVID-19 pandemic required a change in outpatient care delivery models, including shifting from in-person to virtual visits, which may have impacted care of vulnerable patients. Objective To describe the changes in management, control,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60456bb56f64c945720871ae5dcf57a